Retinal vein occlusion is the second most common retinal vascular disorder after diabetic retinopathy and a significant cause of visual impairment.
HISTORY / ORIGIN
Anticoagulant therapy was introduced in 1937 for occlusion of the central retinal vein. The Branch Retinal Vein Occlusion Study (1977-1984) looked at grid laser versus observation. In 2009, the GENEVA study led to the approval of intravitreal dexamethasone implants. The introduction of anti-VEGF therapies reshaped the treatment landscape.
TYPES OF RETINAL VEIN OCCLUSION
Central Retinal Vein Occlusion (CRVO) – Complete blockage
Branch Retinal Vein Occlusion (BRVO) – Partial blockage
MATERIALS / KEY FEATURES
Treatment has evolved from laser therapy to intravitreal steroids and now anti-VEGF agents. These treatments aim to improve vision and prevent complications.
BENEFITS / WHY CHOOSE RETINAL VEIN OCCLUSION TREATMENT
✅ Improves vision outcomes
✅ Reduces the risk of blindness
✅ Multiple treatment options available
✅ Can switch treatments if one fails
✅ Better patient expectations and outcomes
CARE TIPS / USAGE TIPS
Regular eye examinations are essential
Seek immediate medical attention if you experience sudden vision changes
Follow your ophthalmologist's treatment plan
Be aware of risk factors like hypertension and diabetes
ENGAGEMENT QUESTION
💬 Have you or someone you know experienced retinal vein occlusion? What treatment was used and what was the outcome? Share your story below!